This HTML5 document contains 38 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n12http://linked.opendata.cz/resource/drugbank/drug/DB02533/identifier/pdb/
n9http://linked.opendata.cz/resource/drugbank/drug/DB02533/identifier/pubchem-compound/
n10http://linked.opendata.cz/resource/drugbank/drug/DB02533/identifier/pubchem-substance/
n11http://linked.opendata.cz/resource/drugbank/drug/DB02533/identifier/drugbank/
n6http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n7http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n14http://linked.opendata.cz/resource/drugbank/drug/DB02533/identifier/chemspider/
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
n13http://linked.opendata.cz/resource/drugbank/drug/DB02533/identifier/chebi/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB02533
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n6:DB02533 n7:DB02533
dcterms:title
Aminoguanidine
adms:identifier
n9:2146 n10:46506441 n11:DB02533 n12:AGU n13:40618 n14:2061
n3:synthesisReference
John G. Schaffhausen, "Process for the production of aminoguanidine bicarbonate." U.S. Patent US4906778, issued December, 1961.
n3:IUPAC-Name
n4:271B4004-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B400A-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B4009-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B4006-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B4007-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B4008-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B4002-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B4003-363D-11E5-9242-09173F13E4C5 n4:271B4000-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B4001-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B4010-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B4011-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B400B-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B400C-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B400E-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B400D-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B400F-363D-11E5-9242-09173F13E4C5
n3:casRegistryNumber
79-17-4
n3:Bioavailability
n4:271B4015-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B4017-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B4018-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B4014-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B4013-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B4016-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B4005-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B4012-363D-11E5-9242-09173F13E4C5